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In 2011 the World Health Organization's International Agency for Research on Cancer (IARC) 
categorised the radiation fields from mobile phones and other devices that emit similar non-ionizing 
electromagnetic fields (EMFs), as a Group 2B i.e. 'possible' human carcinogen. Nine years earlier 
IARC gave the same classification to the magnetic fields from overhead electric power lines.
The IARC decision on mobile phones was principally based on two sets of case-control human 
studies of possible links between mobile phone use and brain tumours: the IARC Interphone 
study and the Hardell group studies from Sweden. Both provided complementary and generally 
mutually supportive results. This chapter gives an account of the studies by these two groups — 
and others coming to different conclusions — as well as reviews and discussions leading up to 
the IARC decision in 2011. The chapter also describes how different groups have interpreted the 
authoritative IARC evaluation very differently. 
There are by now several meta-analyses and reviews on mobile phones and brain tumours, which 
describe the challenges of doing epidemiology on this issue, the methodological limitations of the 
major studies published so far and the difficulties of interpreting their results.
It has been suggested that national incidence data on brain tumours could be used to qualify or 
disqualify the association between mobile phones and brain tumours observed in the case-control 
studies. However, in addition to methodological shortcomings, there might be other factors 
that influence the overall incidence rate such as changes in exposure to other risk factors for 
brain tumours that are unknown in descriptive studies. Cancer incidence depends on initiation, 
promotion and progression of the disease. As the mechanism for radiofrequency electromagnetic 
fields carcinogenesis is unclear, it supports the view that descriptive data on brain tumour incidence 
is of limited value.
The chapter points to mobile phone industry inertia in considering the various studies and taking 
the IARC carcinogenic classification into account and a failings from the media in providing the 
public with robust and consistent information on potential health risks. The IARC carcinogenic 
classification also appears not to have had any significant impact on governments' perceptions of 
their responsibilities to protect public health from this widespread source of radiation.
The benefits of mobile telecommunications are many but such benefits need to be accompanied 
by consideration of the possibility of widespread harms. Precautionary actions now to reduce head 
exposures would limit the size and seriousness of any brain tumour risk that may exist. Reducing 
exposures may also help to reduce the other possible harms that are not considered in this case 
study.
Evidence is increasing that workers with heavy long-term use of wireless phones who develop 
glioma or acoustic neuroma should be compensated. The first case in the world was established on 
12 October 2012. The Italian Supreme Court affirmed a previous ruling that the Insurance Body for 
Work (INAIL) must grant worker's compensation to a businessman who had used wireless phones 
for 12 years and developed a neuroma in the brain.
(1)  This chapter was supported by grants from Cancer- och Allergifonden and Cancerhjälpen. Contributions by co-workers in the 
various Hardell group publications are acknowledged.Emerging issues | Mobile phone use and brain tumour risk: early warnings, early actions?
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21�1 Introduction
On May 31, 2011 the WHO International Agency for 
Research on Cancer (IARC) categorised the radiation 
fields from mobile phones, and from other devices 
that emit similar non-ionizing electromagnetic 
fields (EMFs), as a Group 2B i.e. a 'possible' human 
carcinogen. Nine years earlier IARC had also 
classified the magnetic fields from overhead electric 
power lines as a Group 2B carcinogen. 
The IARC decision on mobile phones was principally 
based on two sets of case-control human studies: 
the IARC Interphone study and the Hardell group 
studies from Sweden. Both provided complementary 
but generally mutually supportive results. 
But why were these case-control studies into 
possible brain tumours from mobile phones 
initiated? 
21�2  The Hardell group studies — 
1999–2011 
Sweden, along with Israel, was one of the first 
countries in the world to widely adopt wireless 
telecommunications technology. Analogue phones 
(NMT; Nordic Mobile Telephone System) were 
introduced in the early 1980's using both 450 and 
900 Megahertz (MHz) fields. NMT 450 was used in 
Sweden since 1981 but closed down in 31 December, 
2007, whereas NMT 900 operated during 1986–2000. 
The digital system (GSM; Global System for 
Mobile Communication) using dual band, 900 and 
1 800 MHz, started to operate in 1991 and now 
dominates the market. The third generation of 
mobile phones, 3G or UMTS (Universal Mobile 
Telecommunication System), using 1900/2100 
MHz RF fields has been introduced worldwide 
since a few years, in Sweden in 2003. Currently the 
fourth generation, 4G, operating at 800/2 600 MHz, 
and Trunked Radio Communication (TETRA, 
380–400 MHz) are being established in Sweden and 
elsewhere in Europe. 
Desktop cordless phones (e.g. Digital Enhanced 
Cordless Telecommunications; DECT) have been 
used in Sweden since 1988, first using analogue 
800–900 MHz RF fields, but since early 1990's the 
digital 1900 MHz system has been used.
Nowadays mobile phones are used more than 
landline phones in Sweden. (http://www.pts.se/
upload/Rapporter/Tele/2011/sv-telemarknad-halvar-
2011-pts-er-2011-21.pdf).
The real increase in use and exposures to their 
radiation fields has been since the end of the 1990's. 
Wireless phones emit radiofrequency (RF) EMFs 
and the brain is the main target organ during use of 
the handheld phone (Cardis et al., 2008).
One of the author's (LH) interest in this research 
area was initiated by his involvement in a Swedish 
committee that evaluated cancer risks from 
exposure to extremely low frequency (ELF) EMFs 
from power lines. The conclusion was that there 
was an increased risk for childhood leukemia based 
on distance to power lines (Hardell et al., 1995). 
In 2002 IARC concluded that ELF electric and 
magnetic fields from power lines etc. is a human 
Group 2B carcinogen (IARC, 2002). 
From a review of the literature there seemed 
to be an increased risk for brain tumours in the 
electronics industry (Hardell et al., 1995). It was 
decided to study it further in a case-control study. 
However, at that time there was also some media 
attention to a US lawsuit against cell phone 
industry companies. 
It was alleged that repeated use of mobile phone 
had caused a fatal brain tumour in a woman. The 
head line in Los Angeles Times was 'Suit Over 
Cellular Radiation Raises Hazard Questions' (Carlo 
and Schram, 2001). It was therefore decided to 
add questions on mobile phone use in the first 
of 4 linked case-control studies that are briefly 
described below.
This is followed by the results of the other major 
publications with some data on long-term use, the 
Interphone study, and the IARC evaluation of the 
RF and cancer evidence, and related responses and 
discussions. 
The aim is not to give a thorough review of this 
research area, nor to deal with possible other 
effects of RF exposures which can be found in other 
publications including meta-analyses of the risk 
of brain tumours related to use of wireless phones 
(Hardell et al., 2006d; 2009; Myung et al., 2009; 
Kundi, 2009; Cardis and Sadetzki, 2011; Levis et al., 
2011; IARC Monograph, in press).
21�3  First Hardell group study on 
mobile phone use and brain 
tumours — 1999
In 1999 the Hardell group in Sweden published 
results from their first case-control study on brain 
tumours and use of mobile phones (Hardell et al., Emerging issues | Mobile phone use and brain tumour risk: early warnings, early actions?
511 Late lessons from early warnings: science, precaution, innovation
1999a). In total 209 (90 %) of the cases and 425 
(91 %) of the controls that fullfilled the inclusion 
criteria answered the mailed questionnaire. Overall 
no association between use of mobile phones and 
brain tumours was found. 
A slightly increased (but not statistically significant) 
risk was found for analogue phone (NMT) use and 
for a latency period greater than 10 years, Odds Ratio 
(OR) = 1.20 (95 % Confidence Interval; CI = 0.56–2.59). 
For tumours located in the temporal (2), occipital or 
temporoparietal lobe areas of the brain an increased 
risk was found for ipsilateral (3) exposure, OR = 2.42 
(95 % CI = 0.97–6.05) (Hardell et al., 1999a, 2001). 
However, all results were based on low numbers of 
exposed subjects and different histopathological types 
of brain tumours so no firm conclusions could be 
drawn. Furthermore, in this first study use of cordless 
phones was not included.
Authors of an Editorial in 2001, in commenting 
on a 'negative' US study (Inskip et al., 2001) that 
was published after the first Hardell et al. (1999a) 
study, stated that …the use of cellular telephones does 
not detectably increase the risk of brain tumors' and 
that 'This study allays fears raised by alarmist reports 
that the use of cellular telephones causes brain tumors 
(Trichopoulos and Adami, 2001). This statement 
goes far beyond what was scientifically defensible. 
For example, among the 782 patients with brain 
tumours only 22 had 5 years or more of mobile 
phone use and no data with longer latencies were 
presented. The Editorial illustrates a common 
misconception which is that a 'non–positive' study 
is often assumed to be a 'negative' study when in 
fact the data do not support this assumption. 
21�4  Second and third Hardell group 
studies — 2002–2006
This initial study by the Hardell group gave some 
support for an association between use of mobile 
phones and brain tumours. However, the results 
were based on low numbers especially regarding 
tumour type and long-term use. The first study 
was thus followed by two larger studies with cases 
diagnosed during the time period 1997–2003. The 
second study encompassed cases diagnosed during 
1 January 1997 to 30 June 2000 and the third study 
1 July 2000 to 31 December 2003. The methods were 
the same including an identical questionnaire in 
both studies. Results for these two study periods 
were published separately (Hardell et al., 2002, 
2005, 2006a), but here pooled results for the whole 
study period 1997–2003 are presented (Hardell et al., 
2006b, 2006c; Hardell and Carlberg 2009). More 
details can be found in the different publications. 
In short, all cases were reported to a cancer 
registry and had histopathological verfication of 
tumour diagnosis. Both men and women aged 
20–80 years at the time of diagnosis were included. 
Matched controls were identified from the Swedish 
Population Registry. The study included use of 
both mobile and cordless (DECT) phones (wireless 
phones), the latter an exposure which most 
other studies ignore (4). Also questions e.g. about 
occupational exposures were asked. Use of wireless 
phones was assessed by a self-administered 
questionnaire. The information was supplemented 
over the phone, if necessary. 
The ear that had mostly been used during calls with 
mobile phone and/or cordless phone was assessed 
by separate questions; more than 50 % of the time 
for one side, or equally both sides. This information 
was checked during the supplementary phone call. 
Moreover every person that had used a wireless 
phone received after that a letter asking them again 
to specify the ear that had been used during phone 
calls and to what extent that side of the head was 
mostly used. There was a very good agreement for 
the result using these three methods to assess these 
data. 
Separately, tumour localisation was defined by using 
medical records, such as computer tomography 
(CT) and/or magnetic resonance imaging (MRI). 
Use of mobile and cordless phones was defined 
as ipsilateral (more than 50 % of the time), equally 
ipsi/contralateral or contralateral (less than 
50 %) in relation to tumour side. Calculation of 
cumulative hours of use over the years was based 
on information on first and last year of use (time 
period) and average number of minutes per day 
during that period. Use in a car with external 
antenna was disregarded as well as use of a 
handsfree device. A minimum latency period of 
one year was adopted. Hence, latency period and 
cumulative use for the different phone types could 
be defined. 
(2)  A review of 110 phone models showed that exposure to radiations is generally higher in the temporal lobe, which is a part of the 
brain that is near to the ear, (Cardis et al., 2008).
(3)  i.e. the tumour appears on the side of head at which the phone is normally used.
(4)  The Interphone study (see Section 20.9) had some questions on cordless phone use at least in some countries but that information 
has never been properly analysed or published.Emerging issues | Mobile phone use and brain tumour risk: early warnings, early actions?
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Box 21�1  Some concepts and tools for identifying cancer risks in human studies 
OR: Odds ratio� The odds ratio is an estimate of the relative risk, showing how much more likely it is 
that someone who is exposed to a factor (e.g. cell phones) will develop an outcome (e.g. brain tumour) 
compared to someone who is not exposed. An OR of 1 indicates no risk, OR < 1 decreased risk and  
OR > 1 increased risk. For example, an OR of 1.5 indicates that those who are exposed have a 1.5 times 
higher risk of developing a disease compared to those who are not exposed.
SIR: Standardized incidence ratio� The SIR compares the observed number of cases in a specific 
population (e.g. cell phone subscribers) to the number of cases expected would the same rates apply 
as observed in a reference population (e.g. general population). A SIR of 1 indicates no risk,  
SIR < 1 decreased risk and SIR > 1 increased risk.
CI: Confidence interval� A confidence interval shows the uncertainty of the statistical estimate. In the 
case of OR and SIR, if the corresponding CI range does not cover 1.0, the result is considered statistically 
significant. Usually 95 % confidence intervals are reported indicating the range of the true OR/SIR with 
95 % statistical confidence. The absence of 'statistical significance' can often be a weak guide to the 
strength of evidence for a risk compared to the power of a study to detect a risk (5).
Latency period� Time between first exposure and identification of the disease. For cancer, particularly the 
solid tumours like brain cancers in contrast to cancers of the blood, such as leukemia, the latency period 
can be from 15–45 years on average, depending on age at exposure, type and intensity of exposure (6) etc. 
This means that any study of cancer has to be at least as long as the average latent period for the tumour 
being studied before there will be any clear evidence of a cancer risk. 
(5)  See Sir Bradford Hill's classic epidemiology paper, 'The Environment and Disease: Association or Causation?' (Proceedings of the 
Royal Society of Medicine, 1965) where he warned not to overrate the value of statistical significance since it often led people to 
'grasp the shadow and loose the substance' of what was in the data. See Chapter 26 on science for precautionary decision-making.
(6)  Stein, Y., Levy-Nativ, O., Richter, E.D., 'A sentinel case series of cancer patients with occupational exposures to electromagnetic 
non-ionising radiation and other agents', Eur. J. Oncol., 2011, (16/1) 21–54. It has taken almost 50 years to be sure that the 
atomic bomb dropped on Japan in 1945 also caused brain cancers: the data before then were not clear or robust enough. (Shibata, 
Y. et al., 'Intercranial meningiomas among Nagasaki atomic bomb survivors', Lancet, 1994, (344) 1 770). 
21�5  Fourth Hardell group study — 2010
In a review commissioned by the former Swedish 
Radiation Protection Agency (now called the Swedish 
Radiation Safety Authority) it was suggested that the 
exclusion of deceased cases was a source of bias in 
the Hardell group studies (Boice and McLaughlin, 
2002). The scientific reason for this suggestion was not 
given.
As a response to that critique a fourth study was 
performed. This included the cases with a malignant 
brain tumour who had died before inclusion in 
the case-control studies 1997–2003. These cases 
represented patients with a poor prognosis, mostly 
with a astrocytoma grade IV tumour. Controls were 
selected from the Death Registry in Sweden. 
Two groups of controls were included, one group 
consisted of controls that had died from other types 
of malignant diseases than brain tumour and one 
group of controls that had died from other diseases 
than cancer. Relatives to both cases and controls were 
identified through the Swedish Population Registry 
at the Swedish Tax Agency. The study encompassed 
464 cases and 464 controls that had died from a 
malignant disease and 463 controls with other causes 
of death. A similar questionnaire as in previous 
studies was used and exposure was assessed by a 
questionnaire sent to the next of kin to each deceased 
case and control. 
Replies were obtained for 346 (75 %) cases, 343 (74 %) 
cancer controls and 276 (60 %) controls with other 
diseases. Use of mobile phones gave an increased 
risk, highest in the >10 years latency group yielding 
an OR of 2.4 (95 % CI = 1.4–4.1). The risk increased 
with cumulative number of life-time hours of use, 
being highest in the more than 2000 hours group who 
had an OR of 3.4 (95 % CI = 1.6–7.1). Emerging issues | Mobile phone use and brain tumour risk: early warnings, early actions?
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No clear association was found for use of cordless 
phones, although an OR of 1.7 (95 % CI = 0.8–3.4) 
was found in the group with more than 2000 hours 
cumulative use. This investigation confirmed the 
previous results of an association between mobile 
phones and malignant brain tumours (Hardell 
et al., 2010). It was concluded that the critique made 
by Boice and McLaughlin (2002) was scientifically 
unfounded.
21�6  Some Swedish responses to the 
Hardell group studies
The first publication on mobile phone use and brain 
tumour risk (Hardell et al., 1999a) was quickly 
followed by a letter to the journal (Ahlbom and 
Feychting, 1999). They suggested that selection bias of 
cases might have created the high response rate in the 
Hardell study. However, the critique was unfounded 
and easy to rebut (Hardell et al., 1999b). In all of 
the Hardell et al. studies there has usually been a 
high response rate to the oncologists who have been 
trained in cancer epidemiology. This applies as well 
to studies not related to mobile phone use.
Interestingly in the Swedish part of the Interphone 
studies, one of the authors (Anders Ahlbom) 
had stated, even before the study started, that an 
association between cellular telephones and brain 
tumours was biologically bizarre in an 'opinion' letter 
(Adami et al., 2001). Ahlbom's own work provided 
evidence for an association between exposure to 
magnetic fields from overhead power lines and 
childhood leukemia: an association that would also 
have to be regarded as biologically bizarre (Feychting 
and Ahlbom, 1993).
Maria Feychting, who participated in the Swedish 
part of the Interphone studies, queried whether 'the 
questions really were placed in the same way to cases and 
controls' (Björkstén, 2006). Indeed they were in the 
Hardell studies, however, different methods do seem 
to have been used for the interviews with cases and 
controls in the Interphone study, for example, when 
bed-side interviews were done of cases only. 
Meanwhile, the Hardell studies and other evidence 
of possible health risks from EMF inspired a group 
of scientists to summarise this evidence in their 
BioInitiative Report (BioInitiative Working Group, 
2007). This had considerable impact in alerting 
many people to the emerging evidence of risks and 
to the presence of a small but growing minority 
of experts who did not agree with the WHO EMF 
Project statements and other reports that there was no 
evidence of risk (e.g. of SCENIHR 2007). 
The European Environment Agency (EEA), having 
produced a report Late lessons from early warnings 
(EEA, 2001) was invited by the Biointiative group to 
submit a chapter about the relevance of the 14 well 
known 'Late lessons' case studies to the emerging 
issue of EMF. Having considered the published 
evidence, the EEA decided it was timely to issue a 
guarded early warning about the possible risk of 
brain tumours from mobile phones in September 2007 
(see Box 21.2).
21�7  A pooled analysis of the Hardell 
group studies 
Pooled analysis of the two case-control studies 
on brain tumour cases (glioma, meningioma and 
acoustic neuroma (7), Table 21.1) diagnosed for the 
whole time period 1997–2003 was made and results 
were reported for both malignant (Hardell et al., 
2006b) and benign (Hardell, 2006c) tumours. This 
was possible since the same methods were used in 
both studies with an identical questionnaire. In this 
presentation results for glioma in the fourth study 
were added (Hardell et al., 2010; Hardell et al., 2011a). 
Latency was divided in three categories, > 1–5 year, 
> 5–10 year, and > 10 year from first use of a wireless 
phone until diagnosis. Both use of mobile and cordless 
phones gave an increased risk overall for glioma, 
highest in the latency group > 10 years, increasing 
further for ipsilateral use; mobile phone OR of 2.9 
(95 % CI = 1.8–4.7) and cordless phone OR of 3.8 (95 % 
CI = 1.8–8.1). Highest OR was found in the > 10 year 
latency group for total wireless phone use as well. 
Table 21.1 gives the same calculations for 
meningioma (n = 916). There was no consistent 
pattern of an increased risk, although highest risk was 
found for ipsilateral exposure in the > 10 year latency 
period, mobile phone OR = 1.6 (95 % CI = 0.9–2.9). 
Also ipsilateral use of cordless phone in the same 
latency category yielded an increased risk, OR = 3.0 
(95 % CI = 1.3–7.2). 
Regarding acoustic neuroma (n = 243) wireless phone 
use gave OR = 2.2 (95 % CI = 1.3–3.7) in the > 10 y 
latency period. Ipsilateral use gave higher risks than 
contralateral use for both mobile phone and cordless 
phone use. 
(7)  Studying especially long-term use and laterality. Emerging issues | Mobile phone use and brain tumour risk: early warnings, early actions?
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21�8  Risks to children 
Use of wireless phones is widespread among 
children and adolescents (Söderqvist et al., 2007, 
2008). Children's brain absorbs higher radiation from 
RF-EMF emissions than adults (Cardis et al., 2008; 
Christ et al., 2010; Gandhi et al., 2012). This is due 
to the smaller head, thinner skull bone and higher 
conductivity of the brain tissue. The developing brain 
is more sensitive to toxins (Kheifets et al., 2005) and 
the brain is still developing until about 20 years of age 
(Dosenbach et al., 2010). The greater absorption of 
RF energy per unit of time, the greater sensitivity of 
their brain, and the longer lifetimes within which to 
develop a brain tumour leaves children at a higher 
risk than adults from mobile phone radiations. 
Analyses of the Hardell group results revealed 
that first use before age of 20 is associated with the 
highest risk for glioma and acoustic neuroma, see 
Table 21.2 (Hardell, Carlberg, 2009).
Three age groups for first use of a wireless phone 
were used; < 20 years, 20–49 years and 50–80 years. 
For glioma, first use of a mobile phone < 20 y of age 
gave OR = 3.1 (95 % CI = 1.4–6.7). A similar pattern 
was found also for cordless phone use (data not 
shown). Also for acoustic neuroma the risk was 
highest in the youngest age group; OR = 5.0 (95 % 
CI = 1.5–16), but no conclusions could be drawn 
regarding cordless phones since only 1 case had 
first use before the age of 20 years. These ORs 
increased further for ipsilateral mobile phone use 
in the youngest age group; glioma OR = 4.4 (95 % 
CI = 1.3–15), acoustic neuroma OR = 6.8 (95 % 
CI = 1.4–3.4). No clear age dependent pattern of 
increased risk was found for meningioma.
There have been very few other studies of children 
and mobile phone use except the CEFALO study 
(Aydin et al., 2011) and that of the EU, Mobikids (8), 
which is ongoing. 
The multi-centre case–control study CEFALO, 
conducted in Denmark, Sweden, Norway, and 
Switzerland has been commented in detail by 
Söderqvist et al. (2011) since serious methodological 
problems exist as exemplified below. 
In the summary of the study the authors wrote that 
they did not observe that regular use of a mobile phone 
increased the risk for brain tumors. This conclusion was 
accompanied by an editorial stating that the study 
showed no increased risk of brain tumors (Boice and 
Tarone, 2011) as well as by a news release from the 
Karolinska Institute in Stockholm that the results 
of no increased risk were 'reassuring' (Karolinska 
Institute, 2011). However, the statements go far 
beyond what the study really showed.
For example the data collection and analyses of use 
of cordless phones was not valid. Use of cordless 
phones was assessed only in the first 3 years of use, a 
most peculiar definition for which the authors gave 
no explanation for or reference to. Furthermore, 
the study never considered wireless phone use, 
including both mobile and cordless phones, as 
an exposure category. IARC categorised wireless 
phone use as a relevant exposure group (Baan et al., 
2011). Instead, Aydin et al. (2011) included use of 
cordless phones in the 'unexposed' category, so risk 
estimates for mobile phone use might therefore be 
underestimated. Similarly mobile phone use was 
included among the 'unexposed' when considering 
use of cordless phones and thereby potentially 
concealing an increased risk. 
The study yielded a statistically non-significant 
increased risk for brain tumours among regular users 
of mobile phones, OR = 1.36 (95 % CI = 0.92–2.02). 
This OR increased somewhat with cumulative 
duration of subscriptions and duration of calls 
(Aydin et al., 2011). Only latency time of 5 years or 
more was presented with very few cases within this 
category. Further support of a true association was 
found in the results based on operator-recorded use 
for 62 cases and 101 controls, which for time since 
first subscription > 2.8 years yielded a statistically 
significant OR of 2.15 (95 % CI = 1.07–4.29) with a 
statistically significant trend (p = 0.001). 
Although the authors do not emphasize that the 
results yielded an increased risk, the data indicate a 
moderately increased risk, in spite of low exposure, 
short latency period and limitations in study 
design and analyses. Certainly it cannot be used 
as reassuring evidence against an association, as 
discussed in the commentary (Söderqvist et al., 
2011).
Unfortunately, the CEFALO study (Aydin et al., 
2011) was published after the IARC meeting in May 
2011. Had it been available at the IARC meeting 
it would have provided additional evidence to 
support the IARC conclusion that human exposure 
to RF-EMF is a group 2B carcinogen. 
(8) Contact:  ecardis@creal.cat for details.Emerging issues | Mobile phone use and brain tumour risk: early warnings, early actions?
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Box 21�2  The EEA early warnings on brain tumour from mobile phones, 2007–2011 
'There are many examples of the failure to use the precautionary principle in the past, which 
have resulted in serious and often irreversible damage to health and environments. Appropriate, 
precautionary and proportionate actions taken now to avoid plausible and potentially serious threats to 
health from EMF are likely to be seen as prudent and wise from future perspectives' (EEA, 2007).
This early warning was updated in 2009 to include:
'The evidence for a head tumour risk from mobile phones, although still very limited, and much 
contested, is, unfortunately, stronger than two years ago when we first issued our early warning'.
The evidence is now strong enough, using the precautionary principle, to justify the following steps 
(EEA, 2009):
1.  For governments, the mobile phone industry, and the public to take all reasonable measures 
to reduce exposures to EMF, especially to radio frequencies from mobile phones, and 
particularly the exposures to children and young adults who seem to be most at risk from 
head tumours. Such measures would include stopping the use of a mobile phone by placing it next 
to the brain. This can be achieved by the use of texting; hands free sets; and by the use of phones 
of an improved design which could generate less radiation and make it convenient to use hands free 
sets (9).
2.  To reconsider the scientific basis for the present EMF exposure standards which have 
serious limitations such as reliance on the contested thermal effects paradigm; and simplistic 
assumptions about the complexities of radio frequency exposures.
3.  To provide effective labelling and warnings about potential risks for users of mobile phones. 
Across the European Union, the vast majority (80 %) of citizens do not feel that they are informed 
on the existing protection framework relating to potential health risks of electromagnetic fields. 
65 % of citizens say that they are not satisfied with the information they receive concerning the 
potential health risks linked to EMF. (Special Euro barometer report on EMF, Fieldwork Oct/Nov 2006, 
published 2007).
4. To  generate the funds needed to finance and organise the urgently needed research 
into the health effects of phones and associated masts (base stations). Such funds could 
include grants from industry and possibly a small levy on the purchase and or use of 
mobile phones. This idea of a research levy is a practice that we think the US pioneered in the 
rubber industry with a research levy on rubber industry activities in the 1970s when lung and 
stomach cancer was an emerging problem for that industry. The research funds would be used by 
independent bodies (10) (http://latelessons.ew.eea.europa.eu/fol572324/statements/Benefits_of_
mobile_phones_and_potential_hazards_of_EMF.doc).
This was updated in 2011 when evidence was presented to the Council of Europe hearing on mobile 
phones, February 2011 (EEA, 2011a).
(9)  The EEA has since noted, with some relief, what appears to be an increased use of hands free devices, particularly in the younger 
generation, due to enhanced applications.
(10) The EEA has noted the increasing evidence of 'funding bias' in scientific research whereby results outcomes are strongly linked to 
source of funding. This observation is based on evidence from pharmaceuticals, tobacco, lead, asbestos, BPA and EMF, as well as on 
evidence from other fields such as cost-benefit analysis and transport construction project cost estimations.Emerging issues | Mobile phone use and brain tumour risk: early warnings, early actions?
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Table 21�1  Odds ratio (OR) and 95 % confidence interval (CI) for glioma, meningioma and 
acoustic neuroma and use of wireless phones (mobile phones and/or cordless 
phones)
Ipsilateral, 
> 10 year latency
> 10 year latency Total,  
> 1 year latency
OR, CI OR, CI OR, CI
Glioma (n = 1148)
Wireless phone - 2�1 
1�6–2�8
1�3 
1�1–1�5
Mobile phone 2�9 
1�8–4�7
2�5 
1�8–3�3
1�3 
1�1–1�6
Cordless phone 3�8 
1�8–8�1
1�7 
1�1–2�6
1�3 
1�1–1�6
Meningioma (n = 916)
Wireless phone - 1.4 
0.97–2.0
1.0 
0.9–1.2
Mobile phone 1.6 
0.9–2.9
1.4
0.9–2.1
1.1 
0.9–1.3
Cordless phone 3�0 
1�3–7�2
1.6 
0.9–2.8
1.1 
0.9–1.4
Acoustic neuroma (n = 243)
Wireless phone - 2�2 
1�3–3�7
1�5 
1�1–2�0
Mobile phone 3�0 
1�4–6�2
2�6 
1�5–4�6
1�7 
1�2–2�3
Cordless phone 2.3 
0.6–8.8
1.0 
0.3–2.9
1�5 
1�04–2�0
Note:  Bold = statistically signiﬁcant. Number of controls = 2438 in analyses of glioma (living and deceased controls), 2162 for 
meningioma and acoustic neuroma (only living controls). Only living cases and controls included in analyses of ipsilateral use 
of mobile and cordless phones. 
  Adjustment was made for age, gender, socioeconomic-code and year of diagnosis. For glioma adjustment was also made for 
vital status.
Source:  Hardell et al., 2006b, 2006c, 2010, 2011a.
Table 21�2  Odds ratio (OR) and 95 % confidence interval (CI) for glioma, meningioma and 
acoustic neuroma in different age groups for age at first use of a mobile phone 
Note:  Bold = statistically signiﬁcant. Number of controls=2438 in analyses of glioma (living and deceased controls), 2162 for 
meningioma and acoustic neuroma (only living controls).
  Adjustment was made for age, gender, socioeconomic-code, year of diagnosis. For glioma adjustment was also made for vital 
status. 
Source:  Hardell et al., 2006b, 2006c, 2010, 2011a. 
Glioma  
(n = 1148)
Meningioma  
(n = 916)
Acoustic neuroma  
(n = 243)
OR, (CI) OR, (CI) OR, (CI)
Mobile phone 1�3
(1�1–1�6)
1.1
(0.9–1.3)
1�7
(1�2–2�3)
 < 20 years old 3�1
1�4–6�7
1.9
0.6–5.6
5�0
1�5–16
 20–49 years old 1�4
1�1–1�7
1.3
0.99–1.6
2�0
1�3–2�9
 ≥ 50 years old 1�3
1�01–1�6
1.0
0.8–1.3
1.4
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21�9  The Interphone study 2000–2010: 
disagreements and delays 
The Interphone study was an international 
collaboration on brain tumour risk and mobile phone 
use conducted under the guidance of IARC, which is 
an independent agency of WHO. The investigation 
was inititated by recommendations from several 
expert groups to study possible health effects of 
exposure to RF-fields (McKinlay, 1997; Cardis et al., 
2007). It was conducted at 16 research centres in 
13 countries during varying time periods between 
2000 and 2004. It cost nearly EUR 20 million of which 
industry contibuted 5.5 million (IARC, 2010) (11). 
Some of the separate country analyses of the 
Interphone study produced different results, 
with some being positive i.e. finding increased 
brain tumour risks, and some negative i.e. finding 
decreased risks, i.e. seemingly a 'protective' effect of 
the radiation. 
The authors therefore found it hard to come to an 
agreed conclusion and there was a 4 year delay 
between publication of the country results and of 
the overall study results. One group reportedly 
thought that the Interphone study overall had found 
indications of a positive link between mobile phone 
use and brain tumours, especially when the results 
of the 10+ year exposure group were analysed 
separately. Another group thought that they had 
found no indication of a risk and that the apparent 
excess of brain tumour was an artifact of the study 
design and methodology. A third group could agree 
to neither position. 
The publication of the overall Interphone results was 
finally initiated by the Director of IARC, Christopher 
Wild, who brokered sufficient agreement between 
the scientists to finally get the results published in 
May 2010. 
No association between mobile phone use and 
meningioma was found in the overall Interphone 
results whereas subgroup analyses showed 
statistically significant increased risk for glioma 
in the highest exposure group, i.e. those who 
had used their mobile phones for 1 640 hours or 
more, which corresponds to about half an hour 
of use per day for ten years (Interphone Study 
Group, 2010), OR = 1.40 (95 % CI = 1.03–1.89). 
The risk increased further for ipsilateral exposure 
(OR = 1.96, 95 % CI = 1.22–3.16) and for tumours in 
the most exposed part of the brain, the temporal 
lobe, (OR = 1.87, 95 % CI = 1.09–3.22) in the highest 
exposure group for glioma. 
However, the compromise reached between the 
opposing scientists involved the juxtaposition of two 
contrasting sentences that were pointing in different 
directions: There were suggestions of an increased risk 
of glioma, and much less so meningioma, at the highest 
exposure levels, for ipsilateral exposures and, for glioma, 
for tumours in the temporal lobe followed by …biases and 
errors limit the strength of the conclusions we can draw 
from these analyses and prevent a causal [our emphasis] 
interpretation (Interphone Study Group, 2010). 
There was no explanation about how the strength of 
a link between a cause and an effect can vary from a 
'scientific suspicion of risk' to a 'strong association' 
through 'reasonable certainty' and on to 'causality' 
which requires the strongest of evidence. This 
continuum in strengths of evidence, which was 
illustrated in Bradford Hill's paper written at the 
height of the tobacco and lung cancer controversy 
(Hill, 1965), was not explained in the Interphone 
paper. This meant that the media and the public 
could assume that 'not causal' meant 'no link' 
between mobile phones and brain tumours. Other 
epidemiologists did pick up this rather significant 
nuance. 
In an Editorial accompanying the Interphone 
results (Saracci and Samet, 2010), published in the 
International Journal of Epidemiology, the main 
conclusion of the Interphone results, was described 
as both elegant and oracular…(which) tolerates 
diametrically opposite readings. They also pointed out 
several methodological reasons why the Interphone 
results were likely to have underestimated the 
risks, such as the short latency period since first 
exposures became widespread: less than 10 % 
of the Interphone cases had more than 10 years 
exposure. 
None of the today's established carcinogens, including 
tobacco, could have been firmly identified as increasing 
risk in the first 10 years or so since first exposure. 
The 'oracular' concluding sentences from the 
Interphone study therefore allowed the media 
to report opposite conclusions. For example, on 
17 May, 2010 the UK Daily Telegraph reported 
that the Interphone study provided evidence of 
a brain tumour risk from mobile phones (http://
(11) The Hardell studies cost approximately EUR 410 000 and were financed by the Swedish Work Environment Fund, Cancer- och 
Allergifonden, Cancerhjälpen, Telia, Fondkistan, and the Örebro University Hospital Cancer Fund.Emerging issues | Mobile phone use and brain tumour risk: early warnings, early actions?
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www.telegraph.co.uk/health/7729676/Half-an-
hour-of-mobile-use-a-day-increases-brain-cancer-
risk.html) whilst the BBC News reported on the 
same day that there was no risk (http://news.bbc.
co.uk/2/hi/health/8685839.stm). This conflicting 
media reporting pattern was widely repeated 
elsewhere (12). 
Further confusion for the public and policymakers 
followed as a result of the differences in the 
statements of the Interphone scientists reported 
in the media. For example, Microwave News 
reported on 17 May that Elisabeth Cardis, the 
coordinator of the Interphone study, thought 
that Overall...the results show a real effect; Bruce 
Armstrong, the Australian Interphone participant, 
thought that It shows some indication of an increased 
risk of gliomas, but I cannot say this with certainty; 
and Siegal Sadetzki from Israel thought the 
results had consistency in indicating a risk 
but, whilst not strong enough for a causal [our 
emphasis] interpretation, they are sufficient to support 
precautionary policies (http://www.microwavenews.
com/Interphone.Main.html). 
In contrast, another co-author, Feychting, thought, 
the use of mobile phones for over ten years shows no 
increased risk of brain tumours (http://www.i-sis.org.
uk/EEA_Highlight_Mobile_Phone_Cancer_Risks.
php) and Ahlbom, also from the Swedish Interphone 
part, told Chinese Television that there is nothing in 
these data or in previous data, really, to indicate that there 
is any risk involved in this (http://www.youtube.com/
watch?v=TllmreWZdoA).
In later publications of Interphone data the 
estimated RF dose from mobile phone use in the 
tumour area was also associated with an increased 
risk for glioma in parts of the Interphone group. The 
OR increased with increasing total cumulative dose 
of specific energy (J/kg) absorbed at the estimated 
tumour centre for more than 7 years before 
diagnosis with an OR of 1.91 (95 % CI = 1.05–3.47) in 
the highest quintile of exposure (Cardis et al., 2011).
This important result, which for the first time linked 
amount of radiation absorbed (rather than just its 
proxy which is years of exposure/cumulative hours 
of use) to tumour induction, received very little 
media attention. 
A similar study based on less sound methods was 
later published by another part of the Interphone 
study group, see below (Larjavaara et al., 2011).
Results have also now been published for acoustic 
neuroma (Interphone study group, 2011). An 
increased risk was found for start of ipsilateral 
mobile phone use > 10 year before reference 
date and cumulative use > 1 640 h; OR = 3.74 
(95 % CI = 1.58–8.83). 
The total Interphone results for tumours of the 
parotid gland (13) have never been published. Since 
the IARC has now terminated the Interphone 
study (14) only the results from Sweden (Lönn et al., 
2006) and Israel (Sadetzki et al., 2008) are available. 
Subgroup analyses that considered laterality (side 
of use and risk of tumour) and/or amount of use 
(cumulative hours) indicated increased risks. 
However, results from other studies do not indicate 
a consistent pattern of increased risk (Auvinen et al., 
2002; Hardell et al., 2004; Duan et al., 2011; Söderqvist 
et al., 2012a). Results on long-term use are, however, 
scarce. 
21�10 Some reviews and discussions of 
the Hardell group and Interphone 
studies 
There are by now several meta-analyses and reviews 
on mobile phones and cancer and they describe 
the challenges of doing epidemiology on this issue, 
the methodological limitations of the major studies 
published so far and the difficulties of interpreting 
their results.
For example, several of the Interphone findings 
display differential misclassification of exposure 
due to observational and recall bias which would 
tend to underestimate the risk. There were low 
participation rates for both cases and controls in the 
Interphone studies, for example in some countries 
only about 50 % of the cases and about 40 % of the 
controls participated. This is to be compared with 
90 % response rate for cases with malignant brain 
tumours, 88 % for benign and 89 % for controls in 
the Hardell-group studies on living subjects (Hardell 
et al., 2006b, 2006c). Deceased cases were included in 
the calculations of participation in Interphone, but in 
(12) The EEA had anticipated this confusion and had earlier proposed to IARC that the conflicting opinions of the different Interphone 
groups should be published alongside each other, with their different arguments and data interpretations clearly illustrated in the 
same scientific article. This would have helped the media and the public to better understand the reasons for the divergent views 
amongst the Interphone scientists. However, this suggestion was not adopted. 
(13) A tumour in a gland on the cheek in front of the ear.
(14) According to the official website (http://interphone.iarc.fr/) the Interphone Study was completed in February 2012.Emerging issues | Mobile phone use and brain tumour risk: early warnings, early actions?
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the Hardell studies deceased cases were included in a 
separate sub-study on malignant brain tumours.
About 40 % of the cases were interviewed at hospitals 
in the Interphone studies. Further, it was always 
known to the interviewer if it was a case or a control 
that was interviewed. Use of cordless phones was 
not properly assessed in the Interphone study, or 
at least not reported. Further discussion on these 
methodological points may be found elsewhere 
(Hardell et al., 2008; Kundi, 2009).
Myung et al. (2009) subsequently compared methods 
and results in all the published studies on the use of 
mobile phones and the risk for brain tumours. They 
concluded that the Hardell studies were of higher 
quality compared with the Interphone study based on 
the Interphone results from different countries that 
were then available. 
However, one important issue was not covered in the 
Myung et al. (2009) review, namely that the Hardell 
group also assessed use of cordless phones in contrast 
to the Interphone study group. RF-EMF emissions 
from a cordless phone are of the same magnitude 
as that from a digital mobile phone, something that 
has been pointed out several times (Hardell et al., 
2006d; Kundi, 2009; Redmayne et al., 2010). Moreover 
cordless phones are typically used for longer calls 
than mobile phones (Hardell et al., 2006b, 2006c). 
Including cordless phone use in the 'unexposed' 
group, as was done in the Interphone study, would 
bias estimates against a risk. 
The use of bedside interviews of cases, as in the 
Interphone study, can be a major disadvantage and 
is ethically questionable. At that time the patient has 
not fully recovered from e.g. surgery, may not have 
been fully informed about the diagnosis, treatment 
and prognosis and may even be under sedation by 
drugs. In fact patients scored significantly lower than 
controls due to problems in recalling words (aphasia), 
problems with writing and drawing due to paralysis 
in the Danish part of Interphone (Christensen et al., 
2005). Obviously observational bias could have been 
introduced thereby during these bedside interviews. 
In contrast, the Hardell group cases received a postal 
questionnaire approximately 2 months after diagnosis 
and could give the answers in a relaxed manner, a 
situation similar to the controls. All cases and controls 
were later interviewed over the phone to verify and 
clarify different exposures. This was done blinded as 
to case or control status. 
The possibility of recall and observational bias was 
investigated in the second case-control study by 
Hardell et al. (2002). Use of a wireless phone was 
similar among cases and controls regardless if they 
reported a previous cancer or if a relative helped to 
fill in the questionnaire. Potential observational bias 
during phone interviews was analysed by comparing 
change of exposure in cases and controls after these 
interviews. No significant differences were found, 
showing that the results could not be explained by 
observational bias: for further details see discussion in 
that publication (Hardell et al., 2002). All interviews 
were performed by trained persons using structured 
instructions and protocols. 
The article by Myung et al. was commented on 
by e.g. Rowley and Milligan (2010) representing 
the mobile phone industry. They claimed that the 
Interphone studies were independent of industry 
influence. However, the mobile phone industry 
provided 5.5 million euro for the Interphone study 
and additional funding was provided by the industry 
in some countries. Furthermore, according to the 
study protocol Other parties may also be involved in 
the Study Group as observers or consultants. These may 
include representatives of industry, other concerned 
organisations... In addition, representatives of industry 
and other concerned organisations… shall be informed 
shortly (maximum of seven days) before publication, and 
before the scientific community and laymen have 
access to the study results (IARC, 2001).
Rowley and Milligan claim that there is evidence of 
selection, information, and recall bias, and unusually 
high reported participation rates in the Hardell studies 
(Rowley and Milligan, 2010). These ad hoc statements 
are not substantiated by the authors or in their 
references. A high participation rate is a pre-requiste 
for high quality in case-control studies. 
Other scientists have analysed the Hardell results 
more favourably (Kundi, 2009; Myung et al., 2009; 
Mead, 2009; Cardis and Sadetzki, 2011; Levis et al., 
2011) and IARC relied mainly on the Hardell group 
and Interphone study group results for its evaluation 
of the RF evidence. 
The Cardis review was particulary interesting as 
she was the coordinator of the Interphone study. In 
the review with Sadetzki, another Interphone study 
participant, they concluded, after a full discussion of 
the methodological strengths and weaknesses of the 
Hardell and Interphone studies, that:
It is not possible to evaluate the magnitude and 
direction of the different possible biases on the 
study results and to estimate the net effect of 
mobile phones on the risk of brain tumours. The 
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however, suggest the existence of a possible 
association (i.e. between mobile phones and 
brain tumour). 
They ended by concluding that: 
Simple and low cost measures, such as the use of 
text messages, handsfree kits and/or the loudspeaker 
mode of the phone could substantially reduce 
exposure to the brain from mobile phones. Therefore, 
until definitive scientific answers are available, the 
adoption of such precautions, particularly among 
young people, is advisable (Cardis and Sadetzki, 
2011, p. 170).
21�11 IARC evaluation of the 
carcinogenicity of RF-EMFs 2011
In 2011 IARC evaluated the carcinogenic effect to 
humans for RF-EMF emissions during a 8 days 
(24–31 May) meeting at Lyon in France. This 
included all sources of radiofrequency radiation, 
not only mobile and cordless phones. Regarding use 
of wireless phones all of the published studies by 
the Hardell group were included as well as overall 
results for Interphone (Interphone Study Group, 
2010, 2011; Cardis et al., 2011). The results on glioma 
are similar in the Hardell group and Interphone 
studies if the same inclusion and exclusion criteria 
are used (Hardell et al., 2011b). This is in contrast to 
widespread claims that the results of the two sets of 
studies differed significantly. 
The IARC Working Group consisted of 
30 scientists (15) representing four areas: 'animal 
cancer studies', 'epidemiology', 'exposure' and 
'mechanistic and other relevant data'. The different 
expert groups had initially a draft written before the 
meeting by some of the experts. Further work was 
done in the expert groups and a final agreement, 
sentence by sentence, was obtained during plenary 
sessions with all experts participating. 
The Working Group concluded that there is 'limited 
evidence in humans' for the carcinogenicity of RF-
EMF, based on positive associations between glioma 
and acoustic neuroma and exposure to RF-EMF 
from wireless phones. This conclusion was based 
on the Interphone study and the Hardell group 
studies. No conclusions could be drawn from the 
Danish cohort study on mobile phone subscribers 
due to considerable misclassification in exposure 
assessment (Baan et al., 2011).
The final conclusion was obtained by voting by all 
30 scientists and there was a very large majority for 
the conclusion that RF-EMF radiation is 'possibly 
carcinogenic' to humans, Group 2B, based also on 
occupational studies. 
21�12 Some responses to the IARC 
conclusion
It is interesting to see that even the authoritative 
IARC evaluation has been interpreted very 
differently by different groups. 
To date, no adverse health effects have been established as 
being caused by mobile phone use. This was stated in 
a fact sheet in June 2011 from WHO EMF Program 
after the IARC decision (http://www.who.int/
mediacentre/factsheets/fs193/en/), and furthermore 
that Tissue heating is the principal mechanism of 
interaction between radiofrequency energy and the human 
body without acknowledging any of the non-thermal 
effects that could explain the evidence on brain 
tumours (Guiliani and Soffriti, 2010). 
Michael Milligan from the Mobile Manufacturers 
Forum (MMF) said:
…After reviewing the available scientific evidence, 
it is significant that IARC has concluded that 
RF electromagnetic fields are not a definite nor 
a probable human carcinogen… (http://www.
mmfai.org/public/docs/eng/MMF_PR_310511_
IARC.pdf).
Jack Rowley from GSM Association (GSMA) said:
…The IARC classification suggests that a hazard 
is possible but not likely… (http://www.gsma.
com/articles/gsma-statement-on-the-iarc-
classification/17567/).
(15) David Gee of the EEA had been invited by IARC to join the group as 'a representative of your organization, rather than as an 
observer' (for a definition of representatives and observers, please see the Preamble: http://monographs.iarc.fr/ENG/Preamble/
currenta5participants0706.php). However, a few days before the IARC meeting began the EEA wrote to IARC to say they were 
withdrawing because of further delays in publishing the full Interphone results and because of the intellectual bias of Ahlbom who 
was then the Chair of the epidemiology group for the meeting. The day before the meeting began Ahlbom was removed from the 
Chair by IARC as a result of a reported conflict of interest: and the meeting was also given part of the unpublished Interphone data. 
However, this was too late for the EEA to then participate.Emerging issues | Mobile phone use and brain tumour risk: early warnings, early actions?
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Patrick Frostell from the Federation of Finnish 
Technology Industries (FFTI) said:
…IARC's classification is in line with the 
dominant interpretation of current research 
data, according to which radiofrequency 
electromagnetic fields are neither carcinogenic to 
humans nor probably carcinogenic to humans…
(http://www.teknologiateollisuus.fi/en/
news/announcements/2011-6/no-change-in-
international-assessment-of-the-health-effects-
of-mobile-phones).
Professor Dariuz Leszczynski from the Finnish 
Radiation and Nuclear Safety Authority (STUK) and 
member of the IARC expert panel wrote:
Recent IARC evaluation of mobile phone radiation 
potential to cause cancer and classification of it as 
a 2B carcinogen has caused a stir of pro and contra 
opinions among the scientists, industry and news 
media. Unfortunately, the only outcome of this 
broad attention leads to only one — confusion. 
Regular mobile phone user, whether highly or 
not so highly educated, can only be confused by 
this flurry of contradictory opinions and spin-
statements (http://betweenrockandhardplace.
wordpress.com/2011/06/29/%e2%80%a2viva-
confusion/).
The Economist wrote:
..your correspondent thinks the whole brouhaha 
over mobile phones causing brain cancer is 
monumentally irrelevant compared with all the 
other things there are to worry about (http://www.
economist.com/blogs/babbage/2011/06/mobile-
phones-and-health).
Microwave News has followed this area for a 
long time. Much of the whole IARC story and the 
aftermath can be found at its website, for example 
regarding ICNIRP's standpoint: 
ICNIRP is a self-perpetuating group that declines 
to disclose its finances. Its Standing Committee on 
Epidemiology, which wrote the new commentary, 
has only welcomed the like-minded. Its previous 
chairman, Anders Ahlbom, has also registered his 
opinion that cell phone tumor risks are nonexistent. 
(He was the lead author of the last ICNIRP 
review of cell phones and cancer.) Another former 
member, Maria Blettner, was the lone dissenting 
voice in the final vote of the IARC working group. 
Both Blettner and Ahlbom worked on Interphone 
(http://www.microwavenews.com/ICNIRP.
Interphone.html).
Perhaps even IARC has contributed to this confusion 
by seeming to agree with the largely non-positive 
but much criticized Danish cohort study, see below 
(http://www.microwavenews.com).
No doubt the IARC decision started a world-wide 
spinning machine perhaps similar to the one 
launched by the tobacco industry when IARC was 
studying and evaluating passive smoking as a 
carcinogen in the 1990s (Ong and Glanz, 2000) (16). 
Sowing confusion and 'manufacturing doubt' is a 
well known strategy used by the tobacco and other 
industries (Michaels, 2008; McGarity and Wagner, 
2008; Oreskes and Conway, 2010). 
21�13 Some further studies published 
since the IARC conclusion 
The Nordic part of Interphone published a study 
relating brain tumour location to mobile phone 
radiation (Larjavaara et al., 2011). The results 
seemed to contradict the findings by Cardis et al. 
(2011) as discussed above, but used a different, less 
clear method. Only 42 cases had used the mobile 
phone for more than 10 years and no analysis was 
made of the highest exposed group with longest 
duration of use. Thus, this study is much less 
informative and less sophisticated that the one by 
Cardis et al. (2011).
In Denmark a cohort of mobile phone subscribers 
was designed and started in cooperation between The 
International Epidemiology Institute (IEI), Rockville, 
MD, USA, and the Danish Cancer Society. The 
cohort was established by grants from two Danish 
telecom operation companies (TeleDenmark Mobil 
and Sonafon), by IEI, and by the Danish Cancer 
Society. The source of money for the IEI has not been 
disclosed. 
(16) In the early 1990s the Philip Morris tobacco company feared that an IARC study and a possible IARC monograph on second-hand 
smoke would lead to increased restrictions in Europe so they spearheaded an inter-industry, three-prong strategy to subvert 
IARC's work. The scientific strategy attempted to undercut IARC's research and to develop industry-directed research to counter 
the anticipated findings. The communications strategy planned to shape opinion by manipulating the media and the public. The 
government strategy sought to prevent increased smoking restrictions. The IARC study cost USD 2 million over ten years; Philip 
Morris planned to spend USD 2 million in one year alone and up to USD 4 million on research (Ong and Glanz, 2000).Emerging issues | Mobile phone use and brain tumour risk: early warnings, early actions?
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Box 21�3  IARC and its classifications of carcinogens
IARC evaluates the hazard from potential carcinogens, i.e. 'an agent that is capable of causing cancer 
under some circumstances', while a cancer risk is an estimate of the carcinogenic effects expected from an 
exposure to a cancer hazard. The IARC monographs are an exercise in evaluating cancer hazards, despite 
the historical presence of the word 'risks' in the title. 
IARC has categorised nearly 1000 potentially carcinogenic hazardous agents, that it has studied over 
the last 40 years, into 5 classifications. These are differentiated by different strengths of evidence. In 
descending order of strengths of evidence they are: Group 1, which are 'established' human carcinogens, 
such as asbestos, diesel engine exhaust, tobacco, and X-rays (108 agents); Group 2A, which are probable  
carcinogens, such as perchloroethylene (64 agents); Group 2B, which are possible carcinogens, such 
as other traffic fumes, lead, DDT and now radiofrequency electromagnetic fields, including mobile phones 
(272 agents); Group 3, where the agent is not classifiable because the evidence is inadequate and 
does not permit another classification (508 agents); and Group 4, where the agent is probably not 
carcinogenic to humans, based on fairly strong evidence against a cancer effect in both humans and 
animals (1 agent) (IARC, 2012).
It may be helpful to clarify the meaning of the particularly contentious groups. i.e. 2A and 2B.
IARC chooses 3 main different strengths of evidence when it is evaluating the different types of cancer 
evidence that may be available. The evidence evaluated comes mainly from humans; from animals; and 
from consideration of the biological mechanisms for cancer causation: this last can provide understanding 
about how carcinogens cause cancer, in contrast to whether they cause cancer.
The main strengths of evidence groups used by IARC are: 'sufficient', 'limited', and 'inadequate'. For 
example, while Group 1 consists of those agents where there is 'sufficient evidence of carcinogenicity' 
in humans; Group 2A includes those agents where there is 'limited evidence of cancer in humans' but 
'sufficient evidence of cancer in animals'; and Group 2B, which is the radiofrequency EMF category, is 
those agents where there is 'limited evidence of cancer in humans and less than sufficient evidence in 
animals' and where 'chance, bias or confounding cannot be ruled out with reasonable confidence'. 'Evidence 
suggesting lack of carcinogenicity' is used for Group 4 (IARC, 2006, p. 19–20).
Different agents in the same classification group are evaluated on the basis of very different kinds of 
evidence and exposure conditions that are specific for each substance. Some 2B agents will be at the 
lower end of the probability range, others will be close to the nearly one in two probability and the rest 
are somewhere in between, depending on their very specific characteristics. By loosely lumping together 
several randomly chosen carcinogens from the 271 in Group 2B such as dry cleaning fumes and coffee, 
which invites comparison to mobile phones, journalists and others help to complicate the already difficult 
discussion about the likelihood of cancer risks. Each agent needs to be considered on its own evidence.
The first results from the Danish study on brain 
tumour risk among mobile phone subscribers were 
published in 2001 and updated in 2006 and 2011 
(Johansen et al., 2001; Schüz et al., 2006, 2011; Frei 
et al., 2011). It included subjects from 1 January, 
1982 until 31 December, 1995 identified from the 
computerized files of the two Danish operating 
companies, TeleDenmark Mobil and Sonafon. A total 
of 723 421 subscribers were identified but the initial 
cohort consisted of only 58 % of these subscribers. 
The IARC working group's main reason for not using 
the Danish study as evidence for its evaluation was 
that it could have resulted in considerable misclassification 
in exposure assessment (Baan et al., 2011).
The authors of the Danish study have themselves 
pointed out the main causes of such considerable 
exposure misclassification (Frei et al., 2011): mobile 
phone subscription holders not using the phone 
were classified as 'exposed'; non-subscribers 
using the mobile phone were classified as 
'unexposed'; corporate subscribers of mobile 
phones (200 507 people), which are likely to have 
been heavy users, were classified as 'unexposed'; 
persons with a mobile phone subscription later than 
1995 (which is over 80 % of the Danish population) 
were classified as 'unexposed'; and many users of 
cordless phones, which Hardell et al. have linked to 
excess risks of brain cancers, were also classified as 
'unexposed'. Emerging issues | Mobile phone use and brain tumour risk: early warnings, early actions?
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Other limitations are the absence of analysis by 
laterality (the side of head were the phone is used 
in relation to the side of the tumour) and the 
complete absence of actual exposure data. These and 
other shortcomings in this cohort study have been 
discussed elsewhere in more detail (Ahlbom et al., 
2007; Söderqvist et al., 2012b). 
It is clear from these limitations that the authors 
conclusion that 'In this update of a large nationwide 
cohort study of mobile phone use, there were no 
increased risks of tumours of the central nervous 
system, providing little evidence for a causal 
association' is not soundly based (Frei et al., 2011). 
21�14  Need for monitoring long term 
trends in country wide nervous 
system tumours
It has been suggested that overall incidence data 
on brain tumours for countries may be used to 
qualify or disqualify the association between 
mobile phones and brain tumours observed in the 
case-control studies (Aydin et al., 2011; Ahlbom 
and Feychting, 2011; Deltour et al., 2012; Little 
et al., 2012). In support of the findings that Frei 
et al. (2011) presented for Denmark, Ahlbom 
and Feychting (2011) refer to data on overall 
brain tumour incidence from the Swedish Cancer 
Registry (which does not show an overall increase 
in brain tumour incidence since the 1990s) rather 
than from the Danish Cancer Registry which would 
have been more relevant. 
The quality of the Swedish Cancer Registry in 
reporting of central nervous system tumours, 
particularly high grade glioma, has been seriously 
questioned (Bergenheim et al., 2007; Barlow et al., 
2009). In the Deltour et al. paper (2012) Sweden 
accounted for about 40 % of the population and 
cases. Thus, underreporting of brain tumour cases 
to the Swedish Cancer Register would make the 
conclusions in the Deltour et al. study less valid.
In Denmark a statistically significant increase in 
incidence rate per year for brain and central nervous 
system tumours (combined) was seen during 
2000–2009, in men +2.7 % (95 % CI = 1.1 to 4.3) and in 
women + 2.9 % (95 % CI = 0.7 to 5.2) (NORDCAN). 
Recently updated results for brain and central 
nervous system tumours were released in Denmark. 
The age-standardized incidence of brain and central 
nervous system tumours increased by 40 % among 
men and by 29 % among women between 2001–2010 
(Sundhedsstyrelsen, 2010).
A more recent news release based on the Danish 
Cancer Register states that during the last 10 years 
there has been an almost 4-fold increase in the 
incidence of the most malignant glioma type, 
glioblastoma (http://www.cancer.dk/Nyheder/
nyhedsartikler/2012kv4/Kraftig+stigning+i+hjern
esvulster.htm). So far these incidence data are not 
generally available.
Little et al. (2012) studied the incidence rates of 
glioma during 1992–2008 in the United States 
and compared the results with odds ratios for 
glioma associated with mobile phone use in the 
2010 Interphone publication (Interphone Study 
Group, 2010) and the Hardell group pooled results 
published in 2011 (Hardell et al., 2011a). However, 
an important methodological issue that was not 
stated in the abstract or in Figures, but can be 
found in the web appendix, is that observed rates 
were based on men aged 60–64 years from the Los 
Angeles SEER registry as the baseline category. 
These data were used to estimate rates in the entire 
dataset, men and women aged > 18 years and all 
12 SEER registries. Thereby numerous assumptions 
were made. The conclusion by Little et al. that 'Raised 
risk of glioma with mobile phone use, as reported 
by one (Swedish) study … are not consistent with 
observed incidence trends in the US population 
data...' goes far beyond scientific evidence and what 
would be possible to show with the faulty methods 
used in the study. On the contrary, it is of interest that 
they in fact showed statistically significant yearly 
increasing incidence of high-grade glioma in the 
SEER data for 1992–2008, + 0.64 %, 95 % CI 0.33 to 
0.95, a result not commented further by the research 
group. 
Much care is needed when using descriptive data, 
as in Aydin et al. (2011), Deltour et al. (2012) and 
Little et al. (2012), to dismiss results from analytical 
epidemiology. In addition to methodological 
shortcomings, there might be other factors that 
influence the overall incidence rate such as changes 
in exposure to other risk factors for brain tumours 
that are unknown in descriptive studies. Cancer 
incidence depends on initiation, promotion and 
progression of the disease (Hazleton et al., 2005). 
As the mechanism for RF-EMF carcinogenesis is 
unclear it supports the view that descriptive data 
on brain tumour incidence is of limited value. 
21�15 Concluding remarks
It is sometimes claimed by the telecommunications 
industry and others that:Emerging issues | Mobile phone use and brain tumour risk: early warnings, early actions?
524 Late lessons from early warnings: science, precaution, innovation
•  the scientific basis for the current ICNIRP limits 
for exposure to EMF is adequate to protect the 
public from cancer risks; 
•  that children are no more sensitive than adults to 
the RF from mobile phones; 
•  that there are no biologically significant effects 
from non-thermal levels of EMF, and 
•  that, if there are such effects, there are no 
acceptable mechanisms of action that could 
explain these effects. 
However the recent 400-page review by the 
Ramazzini Institute and The International 
Commission for Electromagnetic Safety (ICEMS) 
provides a wealth of evidence on the non–thermal 
biological and ecological effects of EMF (Giuliani 
and Soffritti, 2010). The EEA summarised the main 
findings of this report in its evidence to the Council 
of Europe' hearing on RF and mobile phones in 2011 
(EEA, 2011a, 2011b).
Results from the Hardell-group as well as from 
the Interphone group show an increased risk for 
glioma and acoustic neuroma associated with long 
term mobile phone use. Also use of cordless phones 
increases the risk when properly assessed and 
analysed. The risk is highest for ipsilateral exposure 
to the brain of RF-EMF emissions. Adolescents seem 
to be at higher risk than adults. For meningioma 
there is no consistent pattern of increased risk. 
Furthermore, of interest is that in the same studies 
different results were obtained for different tumour 
types. This strongly argues against systematic 
bias as an explanation of the findings. In that case 
the results would have been similar regardless of 
tumour type.
The IARC conclusion that RF-EMF emissions 
overall, e.g. occupational and from wireless 
phones, are possibly carcinogenic to humans, 
Group 2B (Baan et al., 2011) has been questioned 
by e.g. members of ICNIRP (Swerdlow et al., 2011). 
That article appeared online 1 July, 2011, one month 
after the IARC decision, and concluded that the trend 
in the accumulating evidence is increasingly against the 
hypotheses that mobile phone use can cause brain tumors 
in adults. There has also been unfounded attacks 
on individual researchers as exemplified in this 
article, a pattern that repeats similar experiences in 
the asbestos, lead and tobacco histories. Published 
results on health effects are questioned by using 
obscure methods and citing single results out of 
context without considering the overall pattern. 
There is a lack of investigating journalists who 
can produce nuanced reports in the media. Most 
journalists seem to make only reference to news 
reports or press releases without making their own 
evaluations or without seeming to have read the 
original articles. Many limitations of epidemiological 
studies are to be found in the text, but rarely in 
the abstract which is most often all that is read. 
Without accurate and reliable reporting in the 
media the public do not get a robust and consistent 
information on potential health risks to make their 
own judgements about how precautionary they 
should be. 
It is remarkable that the IARC carcinogenic 
classification does not seem to have had any 
significant impact on governments' perceptions of 
their responsibilities to protect public health from 
this widespread source of radiation, especially 
given the ease with which exposures can be reduced 
(i.e. texting, handsfree devices and better phone 
design). 
Independent research into the many unknowns 
about the biological and ecological effects of RF 
radiations are urgently needed, given the global 
exposure of over 5 billion people and many other 
species, especially those, like bees and some birds 
whose navigation systems are possibly being affected 
by such radiations (Balmori, 2005, 2009; Sharma and 
Kumar, 2010), and effects on breeding of wild birds 
(Everaert and Bauwens, 2007). Research could be in 
part funded by relevant industries from levies on 
phones and masts but used independent from their 
influence. 
The benefits of mobile telecommunications are many, 
but, as with other case studies in the Late lessons from 
early warnings Volume 1 (EEA, 2001) and the present 
report, such benefits need not to be accompanied by 
the possibility of widespread harms. Precautionary 
actions now to reduce head exposures, as pointed out 
by the EEA in 2007, and many others since, would 
limit the size and seriousness of any brain tumour 
risk that may exist. Reducing exposures may also 
help to reduce the other possible harms that are not 
considered in this case study.
21�16 Epilogue
The Italian Supreme Court affirmed a previous 
ruling that the Insurance Body for Work (INAIL) 
must grant worker's compensation to a businessman 
who had used wireless phones for 12 years and 
developed a neurinoma in the brain (http://www.
applelettrosmog.it/public/news.php?id_news=44; Emerging issues | Mobile phone use and brain tumour risk: early warnings, early actions?
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http://microwavenews.com/news-center/italian-
supreme-court-affirms-tumor-risk). He had used 
both mobile and cordless phones for five to six 
hours per day preferably on the same side as the 
tumour developed. The neurinoma was located in 
the trigeminal Gasser's ganglion in the brain. This 
5th cranial nerve controls facial sensations and 
muscles. It is the same type of tumour as the acoustic 
neuroma in the 8th cranial nerve located in the similar 
area of the brain. Although neurinoma is a benign 
tumour it causes persistent disabling symptoms after 
treatment with neurological impairment that severely 
affects the daily life. The Italian case fulfils the criteria 
for a causal association; more than 10 years use of 
wireless phones, high cumulative exposure on the 
same side as the tumour appeared, and a tumour 
type that would be predicted based on previous 
research on use of wireless phones and brain tumour 
risk. No further appeal of the Supreme Court decision 
is possible.
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